Comparison of drug release from metoprolol modified release dosage forms in single buffer versus a pH-gradient dissolution test

Dissolution Technologies

Volumn 13, Issue 1, 2006, Pages 6-12

  Klein, Sandra ^a   Dressman, Jennifer B ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

METOPROLOL;

ARTICLE; DRUG FORMULATION; DRUG RELEASE; EXPERIMENTAL TEST; GASTROINTESTINAL TRACT; GENERAL DEVICE; PH; PH GRADIENT DISSOLUTION TEST; SIMULATION; SINGLE BUFFER TEST; USP APPARATUS 2;

EID: 84962069946     PISSN: 1521298X     EISSN: None     Source Type: Journal    
DOI: 10.14227/DT130106P6     Document Type: Article

References (13)

1. Guidance for Industry: Waiver of in vivo bioavailability and bioequivalence studies for immediate-release solid oral dosage forms based on a biopharmaceutics classification system. U. S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER): Rockville, MD, 2000.
2. Jobin, G., et al. Investigation of drug absorption from the gastrointestinal tract of man. I. Metoprolol in the stomach, duodenum and jejunum. Br. J. Clin. Pharmacol. 1985, 19 (Suppl. 2), 97S-105S.
3. Vidon, N., et al. Investigation of drug absorption from the gastrointestinal tract of man. II. Metoprolol in the jejunum and ileum. Br. J. Clin. Pharmacol. 1985, 19 (Suppl. 2), 107S-112S.
4. Godbillon, J., et al. Investigation of drug absorption from the gastrointestinal tract of man. III. Metoprolol in the colon. Br. J. Clin. Pharmacol. 1985, 19 (Suppl. 2), 113S-118S.
5. Sweetman, S. C., Ed. Martindale: The Complete Drug Reference, 33rd ed.; Pharmaceutical Press: London, England, 2002.
6. Kendall, M. J., et al. Controlled release metoprolol. Clinical pharmacokinetic and therapeutic implications. Clin. Pharmacokinet. 1991, 21 (5), 319-330.
7. United States Pharmacopeia and National Formulary USP 26-NF 21. The United States Pharmacopeial Convention, Inc.: Rockville, MD, 2003.
8. Rohrs, B. R., et al. USP Dissolution Apparatus 3 (Reciprocating Cylinder): Instrument Parameter Effects on Drug release from Sustained Release Formulations. J. Pharm. Sci. 1995, 84 (8), 922-926.
9. Klein, S. Evolution of BioDis® methodology: selection of adequate instrument parameters. In Biorelevant Dissolution Test Methods for Modified Release Dosage Forms. Doctoral Thesis, Institute of Pharmaceutical Technology, Johann Wolfgang Goethe University Frankfurt, Shaker-Verlag: Aachen/Germany, 2005; ISBN 3-8322-4276-7; pp 117-127.
10. Davis, S. S.; Hardy, J. G.; Fara, J. W. Transit of pharmaceutical dosage forms through the small intestine. Gut 1986, 27 (8), 886-892.
11. Moore, J. W.; Flanner, H. H. Mathematical comparison of dissolution profiles. Pharm. Technol. 1996, 20, 64-74.
12. Shah, V. P., et al. Dissolution profile comparison using similarity factor, f2. Dissolution Technologies 1999, 6 (3), 21.
13. Guidance for Industry: SUPAC-MR: Modified Release solid oral dosage forms, in Scale-up and post approval changes: chemistry, manufacturing, and controls; in vitro dissolution testing and in vivo bioequivalence documentation. U. S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER): Rockville, MD, 1997.